Effective prevention of central nervous system leukemia with intrathecal methotrexate and intrathecal methotrexate, cytosine arabinoside, and hydrocortisone in childhood acute lymphocytic leukemia.
Aur
R J
RJ
King Faisal Specialist Hospital and Research Centre, Department of Oncology, Riyadh, Saudi Arabia.
Hanna
M
M
Sabbah
R
R
Sackey
K
K
Willoughby
S
S
Atwood
J
J
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D001932:Brain Neoplasms / Q000517:prevention & control* / Q000532:radiotherapy; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D007223:Infant; D007278:Injections, Spinal; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D012074:Remission Induction; D013120:Spinal Cord Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D013736:Testicular Neoplasms / Q000532:radiotherapy
D003561:Cytarabine; D006854:Hydrocortisone; D008727:Methotrexate